Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9B757
Term | Name | Level | Count |
---|---|---|---|
GO:0002181 | cytoplasmic translation | 5 | 1 |
GO:0006412 | translation | 4 | 1 |
GO:0006518 | peptide metabolic process | 4 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009059 | macromolecule biosynthetic process | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034645 | obsolete cellular macromolecule biosynthetic process | 4 | 1 |
GO:0043043 | peptide biosynthetic process | 5 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043603 | amide metabolic process | 3 | 1 |
GO:0043604 | amide biosynthetic process | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0003924 | GTPase activity | 7 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0005525 | GTP binding | 5 | 12 |
GO:0016462 | pyrophosphatase activity | 5 | 12 |
GO:0016787 | hydrolase activity | 2 | 12 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 3 | 12 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4 | 12 |
GO:0017076 | purine nucleotide binding | 4 | 12 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 6 | 12 |
GO:0019001 | guanyl nucleotide binding | 5 | 12 |
GO:0032553 | ribonucleotide binding | 3 | 12 |
GO:0032555 | purine ribonucleotide binding | 4 | 12 |
GO:0032561 | guanyl ribonucleotide binding | 5 | 12 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 12 |
GO:0036094 | small molecule binding | 2 | 12 |
GO:0043167 | ion binding | 2 | 12 |
GO:0043168 | anion binding | 3 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0097367 | carbohydrate derivative binding | 2 | 12 |
GO:1901265 | nucleoside phosphate binding | 3 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 241 | 243 | PF00675 | 0.240 |
CLV_NRD_NRD_1 | 59 | 61 | PF00675 | 0.473 |
CLV_NRD_NRD_1 | 6 | 8 | PF00675 | 0.420 |
CLV_PCSK_KEX2_1 | 316 | 318 | PF00082 | 0.238 |
CLV_PCSK_KEX2_1 | 326 | 328 | PF00082 | 0.238 |
CLV_PCSK_KEX2_1 | 6 | 8 | PF00082 | 0.421 |
CLV_PCSK_PC1ET2_1 | 316 | 318 | PF00082 | 0.238 |
CLV_PCSK_PC1ET2_1 | 326 | 328 | PF00082 | 0.238 |
CLV_PCSK_SKI1_1 | 210 | 214 | PF00082 | 0.238 |
CLV_PCSK_SKI1_1 | 337 | 341 | PF00082 | 0.249 |
CLV_PCSK_SKI1_1 | 66 | 70 | PF00082 | 0.238 |
DOC_MAPK_gen_1 | 182 | 191 | PF00069 | 0.576 |
DOC_MAPK_gen_1 | 242 | 250 | PF00069 | 0.438 |
DOC_MAPK_gen_1 | 264 | 274 | PF00069 | 0.438 |
DOC_MAPK_MEF2A_6 | 140 | 149 | PF00069 | 0.438 |
DOC_MAPK_MEF2A_6 | 242 | 250 | PF00069 | 0.438 |
DOC_MAPK_MEF2A_6 | 267 | 276 | PF00069 | 0.438 |
DOC_MAPK_RevD_3 | 168 | 183 | PF00069 | 0.381 |
DOC_PP2B_LxvP_1 | 116 | 119 | PF13499 | 0.429 |
DOC_PP4_FxxP_1 | 309 | 312 | PF00568 | 0.438 |
DOC_USP7_MATH_1 | 156 | 160 | PF00917 | 0.464 |
DOC_USP7_UBL2_3 | 105 | 109 | PF12436 | 0.463 |
DOC_USP7_UBL2_3 | 210 | 214 | PF12436 | 0.438 |
DOC_USP7_UBL2_3 | 326 | 330 | PF12436 | 0.463 |
LIG_14-3-3_CanoR_1 | 202 | 209 | PF00244 | 0.516 |
LIG_14-3-3_CanoR_1 | 267 | 273 | PF00244 | 0.467 |
LIG_APCC_ABBA_1 | 274 | 279 | PF00400 | 0.447 |
LIG_Dynein_DLC8_1 | 81 | 87 | PF01221 | 0.513 |
LIG_FHA_1 | 199 | 205 | PF00498 | 0.456 |
LIG_FHA_2 | 256 | 262 | PF00498 | 0.449 |
LIG_FHA_2 | 83 | 89 | PF00498 | 0.442 |
LIG_GBD_Chelix_1 | 272 | 280 | PF00786 | 0.238 |
LIG_LIR_Apic_2 | 308 | 312 | PF02991 | 0.438 |
LIG_LIR_Gen_1 | 232 | 238 | PF02991 | 0.449 |
LIG_LIR_Gen_1 | 287 | 298 | PF02991 | 0.438 |
LIG_LIR_Gen_1 | 95 | 103 | PF02991 | 0.439 |
LIG_LIR_Nem_3 | 215 | 219 | PF02991 | 0.505 |
LIG_LIR_Nem_3 | 232 | 237 | PF02991 | 0.347 |
LIG_LIR_Nem_3 | 287 | 293 | PF02991 | 0.438 |
LIG_LIR_Nem_3 | 95 | 99 | PF02991 | 0.439 |
LIG_Pex14_2 | 309 | 313 | PF04695 | 0.440 |
LIG_PTB_Apo_2 | 175 | 182 | PF02174 | 0.425 |
LIG_SH2_NCK_1 | 251 | 255 | PF00017 | 0.438 |
LIG_SH2_STAP1 | 194 | 198 | PF00017 | 0.499 |
LIG_SH2_STAP1 | 338 | 342 | PF00017 | 0.438 |
LIG_SH2_STAT5 | 249 | 252 | PF00017 | 0.428 |
LIG_SH2_STAT5 | 299 | 302 | PF00017 | 0.438 |
LIG_SH3_3 | 67 | 73 | PF00018 | 0.438 |
LIG_SUMO_SIM_anti_2 | 143 | 150 | PF11976 | 0.451 |
LIG_SUMO_SIM_par_1 | 145 | 150 | PF11976 | 0.437 |
LIG_TRAF2_1 | 258 | 261 | PF00917 | 0.438 |
LIG_TRAF2_1 | 9 | 12 | PF00917 | 0.394 |
LIG_UBA3_1 | 144 | 153 | PF00899 | 0.306 |
LIG_UBA3_1 | 295 | 302 | PF00899 | 0.306 |
MOD_CK1_1 | 193 | 199 | PF00069 | 0.330 |
MOD_CK1_1 | 79 | 85 | PF00069 | 0.306 |
MOD_CK2_1 | 156 | 162 | PF00069 | 0.338 |
MOD_CK2_1 | 255 | 261 | PF00069 | 0.306 |
MOD_CK2_1 | 368 | 374 | PF00069 | 0.457 |
MOD_CK2_1 | 82 | 88 | PF00069 | 0.296 |
MOD_GlcNHglycan | 344 | 347 | PF01048 | 0.325 |
MOD_GlcNHglycan | 61 | 64 | PF01048 | 0.423 |
MOD_GSK3_1 | 190 | 197 | PF00069 | 0.295 |
MOD_GSK3_1 | 198 | 205 | PF00069 | 0.288 |
MOD_GSK3_1 | 268 | 275 | PF00069 | 0.346 |
MOD_GSK3_1 | 71 | 78 | PF00069 | 0.290 |
MOD_GSK3_1 | 82 | 89 | PF00069 | 0.290 |
MOD_N-GLC_1 | 177 | 182 | PF02516 | 0.400 |
MOD_NEK2_1 | 368 | 373 | PF00069 | 0.432 |
MOD_NEK2_2 | 177 | 182 | PF00069 | 0.380 |
MOD_PIKK_1 | 14 | 20 | PF00454 | 0.452 |
MOD_PIKK_1 | 82 | 88 | PF00454 | 0.379 |
MOD_PK_1 | 317 | 323 | PF00069 | 0.348 |
MOD_PKA_1 | 182 | 188 | PF00069 | 0.455 |
MOD_PKA_2 | 263 | 269 | PF00069 | 0.297 |
MOD_PKA_2 | 59 | 65 | PF00069 | 0.435 |
MOD_PKA_2 | 82 | 88 | PF00069 | 0.276 |
MOD_Plk_1 | 177 | 183 | PF00069 | 0.391 |
MOD_Plk_1 | 227 | 233 | PF00069 | 0.290 |
MOD_Plk_1 | 317 | 323 | PF00069 | 0.348 |
MOD_Plk_1 | 94 | 100 | PF00069 | 0.278 |
MOD_Plk_2-3 | 227 | 233 | PF00069 | 0.290 |
MOD_Plk_2-3 | 255 | 261 | PF00069 | 0.306 |
MOD_Plk_4 | 268 | 274 | PF00069 | 0.339 |
MOD_Plk_4 | 76 | 82 | PF00069 | 0.290 |
MOD_SUMO_for_1 | 152 | 155 | PF00179 | 0.318 |
MOD_SUMO_for_1 | 37 | 40 | PF00179 | 0.426 |
TRG_DiLeu_BaEn_4 | 260 | 266 | PF01217 | 0.290 |
TRG_ENDOCYTIC_2 | 216 | 219 | PF00928 | 0.411 |
TRG_ENDOCYTIC_2 | 251 | 254 | PF00928 | 0.290 |
TRG_ENDOCYTIC_2 | 338 | 341 | PF00928 | 0.290 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7B2 | Leptomonas seymouri | 49% | 100% |
A0A0N1I7A1 | Leptomonas seymouri | 95% | 100% |
A0A0S4JLR9 | Bodo saltans | 83% | 100% |
A0A0S4JSR7 | Bodo saltans | 50% | 100% |
A0A1X0P4R4 | Trypanosomatidae | 89% | 100% |
A0A1X0P8M9 | Trypanosomatidae | 50% | 100% |
A0A3Q8IK74 | Leishmania donovani | 50% | 100% |
A0A3S7XAC8 | Leishmania donovani | 99% | 100% |
A0A422N5U7 | Trypanosoma rangeli | 87% | 100% |
A0A422NIT8 | Trypanosoma rangeli | 50% | 100% |
A4HNJ2 | Leishmania braziliensis | 95% | 100% |
A4HP94 | Leishmania braziliensis | 49% | 99% |
A4IC49 | Leishmania infantum | 99% | 100% |
A4IDJ9 | Leishmania infantum | 50% | 100% |
C9ZYC5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 87% | 100% |
D0A397 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 51% | 100% |
E9AG04 | Leishmania major | 99% | 100% |
E9AT02 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 49% | 99% |
P17103 | Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) | 38% | 100% |
P32233 | Mus musculus | 51% | 100% |
P32234 | Drosophila melanogaster | 50% | 100% |
P32235 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 54% | 100% |
P34280 | Caenorhabditis elegans | 56% | 100% |
P39729 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 49% | 100% |
P43690 | Xenopus laevis | 51% | 100% |
P53295 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 52% | 100% |
P55039 | Homo sapiens | 61% | 100% |
Q3MHP5 | Bos taurus | 51% | 100% |
Q4Q1J6 | Leishmania major | 49% | 99% |
Q54HP3 | Dictyostelium discoideum | 52% | 100% |
Q54WT4 | Dictyostelium discoideum | 55% | 100% |
Q58722 | Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) | 45% | 96% |
Q58D56 | Bos taurus | 60% | 100% |
Q9CAI1 | Arabidopsis thaliana | 51% | 94% |
Q9LQK0 | Arabidopsis thaliana | 52% | 94% |
Q9QXB9 | Mus musculus | 60% | 100% |
Q9SVA6 | Arabidopsis thaliana | 52% | 100% |
Q9UT21 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 45% | 100% |
Q9Y295 | Homo sapiens | 51% | 100% |
V5BKY5 | Trypanosoma cruzi | 50% | 76% |
V5DQF8 | Trypanosoma cruzi | 87% | 100% |